PK3C3_HUMAN - dbPTM
PK3C3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PK3C3_HUMAN
UniProt AC Q8NEB9
Protein Name Phosphatidylinositol 3-kinase catalytic subunit type 3
Gene Name PIK3C3 {ECO:0000312|HGNC:HGNC:8974}
Organism Homo sapiens (Human).
Sequence Length 887
Subcellular Localization Midbody . Late endosome . Cytoplasmic vesicle, autophagosome . As component of the PI3K complex I localized to pre-autophagosome structures. As component of the PI3K complex II localized predominantly to endosomes (Probable). Localizes also to discre
Protein Description Catalytic subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and required for the abcission step in cytokinesis, probably in the context of PI3KC3-C2. [PubMed: 20643123]
Protein Sequence MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
25PhosphorylationNVQLKIGSLEGKREQ
EEEEEECCCCCHHHH
27.0719369195
29AcetylationKIGSLEGKREQKSYK
EECCCCCHHHHHHHH
43.30560012611
29UbiquitinationKIGSLEGKREQKSYK
EECCCCCHHHHHHHH
43.30-
34AcetylationEGKREQKSYKAVLED
CCHHHHHHHHHHHCC
31.4019413330
36UbiquitinationKREQKSYKAVLEDPM
HHHHHHHHHHHCCCC
38.83-
36MethylationKREQKSYKAVLEDPM
HHHHHHHHHHHCCCC
38.83115974985
96UbiquitinationEWLKLPVKYPDLPRN
HHCCCCCCCCCCCCC
49.48-
109PhosphorylationRNAQVALTIWDVYGP
CCCEEEEEEEECCCC
15.4130576142
114PhosphorylationALTIWDVYGPGKAVP
EEEEEECCCCCCEEC
18.3530576142
125PhosphorylationKAVPVGGTTVSLFGK
CEECCCCEEEEHHHH
20.3521406692
126PhosphorylationAVPVGGTTVSLFGKY
EECCCCEEEEHHHHC
16.0421406692
128PhosphorylationPVGGTTVSLFGKYGM
CCCCEEEEHHHHCCH
18.8521406692
132UbiquitinationTTVSLFGKYGMFRQG
EEEEHHHHCCHHHCC
31.15-
132AcetylationTTVSLFGKYGMFRQG
EEEEHHHHCCHHHCC
31.1525953088
133PhosphorylationTVSLFGKYGMFRQGM
EEEHHHHCCHHHCCC
17.7530576142
144UbiquitinationRQGMHDLKVWPNVEA
HCCCCCCCCCCCCCC
48.59-
158UbiquitinationADGSEPTKTPGRTSS
CCCCCCCCCCCCCCC
64.5421906983
159PhosphorylationDGSEPTKTPGRTSST
CCCCCCCCCCCCCCC
33.1920513426
163PhosphorylationPTKTPGRTSSTLSED
CCCCCCCCCCCCCHH
32.7020513426
164PhosphorylationTKTPGRTSSTLSEDQ
CCCCCCCCCCCCHHH
21.6920513426
165PhosphorylationKTPGRTSSTLSEDQM
CCCCCCCCCCCHHHH
32.5228857561
168PhosphorylationGRTSSTLSEDQMSRL
CCCCCCCCHHHHHHH
38.93-
179PhosphorylationMSRLAKLTKAHRQGH
HHHHHHHHHHHHCCC
26.0226437602
207PhosphorylationEIEMINESEKRSSNF
HHEECCCCHHCCCCC
43.8822210691
209UbiquitinationEMINESEKRSSNFMY
EECCCCHHCCCCCEE
67.85-
229UbiquitinationRCVKCDDKEYGIVYY
EEEECCCCEEEEEEE
39.31-
231PhosphorylationVKCDDKEYGIVYYEK
EECCCCEEEEEEEEE
20.2127642862
238UbiquitinationYGIVYYEKDGDESSP
EEEEEEEECCCCCCC
51.38-
243PhosphorylationYEKDGDESSPILTSF
EEECCCCCCCEEEEE
46.2729255136
244PhosphorylationEKDGDESSPILTSFE
EECCCCCCCEEEEEE
17.5719664994
248PhosphorylationDESSPILTSFELVKV
CCCCCEEEEEEEEEC
31.9029255136
249PhosphorylationESSPILTSFELVKVP
CCCCEEEEEEEEECC
17.1829255136
261PhosphorylationKVPDPQMSMENLVES
ECCCCCCCHHHHHHH
20.0719369195
268PhosphorylationSMENLVESKHHKLAR
CHHHHHHHHHHHHHH
29.7917494752
269UbiquitinationMENLVESKHHKLARS
HHHHHHHHHHHHHHH
35.90-
276PhosphorylationKHHKLARSLRSGPSD
HHHHHHHHHHCCCCC
23.6424719451
279PhosphorylationKLARSLRSGPSDHDL
HHHHHHHCCCCCCCC
61.4223186163
282PhosphorylationRSLRSGPSDHDLKPN
HHHHCCCCCCCCCCC
51.6130108239
287UbiquitinationGPSDHDLKPNAATRD
CCCCCCCCCCCCCHH
42.13-
287MethylationGPSDHDLKPNAATRD
CCCCCCCCCCCCCHH
42.13-
305PhosphorylationIIVSYPPTKQLTYEE
EEEECCCCCCCCHHH
27.24-
310PhosphorylationPPTKQLTYEEQDLVW
CCCCCCCHHHHHHHH
26.51-
321PhosphorylationDLVWKFRYYLTNQEK
HHHHHHHHHHHCHHH
13.1323403867
322PhosphorylationLVWKFRYYLTNQEKA
HHHHHHHHHHCHHHH
11.6423403867
324PhosphorylationWKFRYYLTNQEKALT
HHHHHHHHCHHHHHH
20.8023403867
328UbiquitinationYYLTNQEKALTKFLK
HHHHCHHHHHHHHHH
38.64-
346UbiquitinationWDLPQEAKQALELLG
CCCCHHHHHHHHHHC
35.04-
379PhosphorylationTNPTVRRYAVARLRQ
CCHHHHHHHHHHHHC
8.55-
395PhosphorylationDDEDLLMYLLQLVQA
CHHHHHHHHHHHHHH
12.29-
412UbiquitinationYENFDDIKNGLEPTK
CCCHHHHHCCCCCCC
52.54-
448PhosphorylationDSSQIITSPLPSVSS
CHHHEECCCCCCCCC
17.6517192257
452PhosphorylationIITSPLPSVSSPPPA
EECCCCCCCCCCCCC
42.1722199227
454PhosphorylationTSPLPSVSSPPPASK
CCCCCCCCCCCCCCC
41.2722199227
455PhosphorylationSPLPSVSSPPPASKT
CCCCCCCCCCCCCCC
38.9917192257
460PhosphorylationVSSPPPASKTKEVPD
CCCCCCCCCCCCCCC
46.7822199227
463UbiquitinationPPPASKTKEVPDGEN
CCCCCCCCCCCCCCC
61.52-
488PhosphorylationSRACKNSTLANYLYW
HHHHCCCHHHHHEEE
39.00-
513PhosphorylationTQQRDPKTHEMYLNV
CCCCCCCHHHHHHHH
28.5818187866
517PhosphorylationDPKTHEMYLNVMRRF
CCCHHHHHHHHHHHH
7.6718187866
525PhosphorylationLNVMRRFSQALLKGD
HHHHHHHHHHHHCCC
16.8420873877
534PhosphorylationALLKGDKSVRVMRSL
HHHCCCHHHHHHHHH
21.6424260401
547PhosphorylationSLLAAQQTFVDRLVH
HHHHHHHHHHHHHHH
17.3422210691
557AcetylationDRLVHLMKAVQRESG
HHHHHHHHHHHHHCC
52.3325953088
582UbiquitinationALLGDNEKMNLSDVE
HHHCCCCCCCCCCCE
39.07-
600UbiquitinationLPLEPQVKIRGIIPE
CCCCCCCEEEEECHH
22.80-
613MethylationPETATLFKSALMPAQ
HHHHHHHHHHHCEEE
37.62115974993
617SulfoxidationTLFKSALMPAQLFFK
HHHHHHHCEEEEEEE
2.3021406390
624AcetylationMPAQLFFKTEDGGKY
CEEEEEEECCCCCEE
43.6119413330
625PhosphorylationPAQLFFKTEDGGKYP
EEEEEEECCCCCEEE
33.8719413330
630UbiquitinationFKTEDGGKYPVIFKH
EECCCCCEEEEEEEC
52.492189047
631PhosphorylationKTEDGGKYPVIFKHG
ECCCCCEEEEEEECC
13.1524719451
666UbiquitinationRKENLDLKLTPYKVL
HHCCCCCCCCCCEEE
50.40-
668PhosphorylationENLDLKLTPYKVLAT
CCCCCCCCCCEEEEE
24.0020513426
670PhosphorylationLDLKLTPYKVLATST
CCCCCCCCEEEEECC
14.4320049867
706UbiquitinationSIQNFFRKYAPSENG
HHHHHHHHHCCCCCC
40.38-
771AcetylationYILGRDPKPLPPPMK
CCCCCCCCCCCCCCC
64.57560012599
781UbiquitinationPPPMKLNKEMVEGMG
CCCCCCCHHHHCCCC
58.59-
781AcetylationPPPMKLNKEMVEGMG
CCCCCCCHHHHCCCC
58.59560012605
790PhosphorylationMVEGMGGTQSEQYQE
HHCCCCCCCHHHHHH
24.1626437602
795PhosphorylationGGTQSEQYQEFRKQC
CCCCHHHHHHHHHHH
13.1224114839
803PhosphorylationQEFRKQCYTAFLHLR
HHHHHHHHHHHHHHH
9.90-
840SumoylationLEPDKTVKKVQDKFR
CCCCCHHHHHHHHHC
53.08-
840SumoylationLEPDKTVKKVQDKFR
CCCCCHHHHHHHHHC
53.08-
845SumoylationTVKKVQDKFRLDLSD
HHHHHHHHHCCCCCH
18.45-
845SumoylationTVKKVQDKFRLDLSD
HHHHHHHHHCCCCCH
18.45-
884PhosphorylationQIHKFAQYWRK----
HHHHHHHHHHC----
12.07-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
159TPhosphorylationKinaseCDK1P06493
PSP
159TPhosphorylationKinaseCDK5Q00535
PSP
163TPhosphorylationKinaseAMPKQ9Y478
Uniprot
165SPhosphorylationKinaseAMPKQ9Y478
Uniprot
249SPhosphorylationKinaseULK1O75385
PSP
249SPhosphorylationKinaseULK2Q8IYT8
PSP
249SPhosphorylationKinaseULK3Q6PHR2
PSP
668TPhosphorylationKinaseCDK5Q00535
PSP
-KUbiquitinationE3 ubiquitin ligaseKLHL20Q9Y2M5
PMID:26687681

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PK3C3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PK3C3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PI3R4_HUMANPIK3R4physical
20562859
UVRAG_HUMANUVRAGphysical
20562859
BAKOR_HUMANATG14physical
20562859
CLP1L_HUMANCLPTM1Lphysical
20562859
NRBF2_HUMANNRBF2physical
20562859
BECN1_HUMANBECN1physical
20562859
RUBIC_HUMANKIAA0226physical
20562859
UBP11_HUMANUSP11physical
20562859
BECN1_HUMANBECN1physical
21936852
BECN1_HUMANBECN1physical
18628207
MYH9_HUMANMYH9physical
23569248
MYH1_HUMANMYH1physical
23569248
KIF1B_HUMANKIF1Bphysical
23569248
DREB_HUMANDBN1physical
23569248
TIF1B_HUMANTRIM28physical
23569248
HS90A_HUMANHSP90AA1physical
23569248
GRP78_HUMANHSPA5physical
23569248
ANM5_HUMANPRMT5physical
23569248
BECN1_HUMANBECN1physical
18843052
UVRAG_HUMANUVRAGphysical
18843052
BAKOR_HUMANATG14physical
18843052
BAKOR_HUMANATG14physical
19050071
BECN1_HUMANBECN1physical
19050071
PI3R4_HUMANPIK3R4physical
26344197
UBP18_HUMANUSP18physical
25906440
BECN1_HUMANBECN1physical
28757208
PI3R4_HUMANPIK3R4physical
28757208

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PK3C3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25; THR-163; SER-165;SER-244; SER-261; SER-452; SER-454 AND SER-455, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-448 ANDSER-455, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-625, AND MASSSPECTROMETRY.

TOP